EcoDrugPlus

Ensembl ID : ML234566a
Gene Symbol: -
External references: -
74 Possible Orthologues:

Ensembl ID : ML23836a
Gene Symbol: -
External references: -
74 Possible Orthologues:

Ensembl ID : ML24671a
Gene Symbol: -
External references: -
431 Possible Orthologues:

Ensembl ID : ML252810a
Gene Symbol: -
External references: -
100 Possible Orthologues:

Ensembl ID : ML25282a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML258222a
Gene Symbol: -
External references: -
197 Possible Orthologues:

Ensembl ID : ML258242a
Gene Symbol: -
External references: -
203 Possible Orthologues:

Ensembl ID : ML26175a
Gene Symbol: -
External references: -
73 Possible Orthologues:

Ensembl ID : ML26624a
Gene Symbol: -
External references: -
59 Possible Orthologues:

Ensembl ID : ML26626a
Gene Symbol: -
External references: -
197 Possible Orthologues:

Ensembl ID : ML26922a
Gene Symbol: -
External references: -
147 Possible Orthologues:

Ensembl ID : ML26931a
Gene Symbol: -
External references: -
166 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).